An article published in 'El Médico Interactivo', prepared by a group of Galician doctors, in which they show that biosimilar medicines undergo a scientific evaluation before being marketed, in order to guarantee that their quality, safety and efficacy expected to be the same as those of the reference medicine.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
